🟢 Capricor Therapeutics is trading 5% up today with no clear company-specific catalyst

Capricor Therapeutics is trading at $9.36 (+5.17%) with no clear company-specific catalyst identified for the September 22, 2026 gain.

• Recent coverage highlights securities-fraud lawsuit reminders and a September 28 lead-plaintiff deadline, developments that do not directly explain the upward move.
• The broader market is modestly positive, but major-index gains remain below the threshold for confidently attributing this move to macro sentiment.
• Trading activity details were unavailable; recheck the catalyst as additional disclosures emerge.